Skip to main content

Day: May 19, 2020

Tonix Pharmaceuticals Announces Appointment of Herbert Harris, M.D., Ph.D., as Executive Vice President, Translational Medicine

NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of Herbert Harris, M.D., Ph.D., as its new Executive Vice President, Translational Medicine, effective May 15, 2020. In this role, Dr. Harris will focus on advancing Tonix’s pre-clinical pipeline, including the potential COVID-19 vaccine into the clinic, as well as participate in Tonix’s ongoing clinical programs.Dr. Gregory Sullivan, Chief Medical Officer of Tonix said, “The recruitment of Dr. Harris to our management team is opportune, arriving at a time Tonix has launched its COVID-19 program and expanded its pipeline of clinical candidates including those in addiction, mood disorders, and geriatric psychiatry. Dr. Harris’ career has exemplified...

Continue reading

XPO Logistics Again Ranked No. 1 in Transportation and Logistics on Fortune 500

GREENWICH, Conn., May 19, 2020 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of supply chain solutions, ranks No. 1 in the Fortune 500 category of transportation and logistics for the fourth straight year, as announced by Fortune magazine today. The company ranks No. 196 on the Fortune 500 overall, based on 2019 revenue of $16.6 billion.Bradley Jacobs, chairman and chief executive officer of XPO Logistics, said, “XPO is honored to once again be among the top 200 on the Fortune 500 list and lead the transportation and logistics category. We’re using our strengths to rigorously safeguard our people while keeping goods flowing through supply chains.”In January, Fortune named XPO one of the World’s Most Admired Companies for the third straight year for the quality of the company’s performance and culture.About...

Continue reading

Corvus Gold Expands Exploration Focus for New Mother Lode and Bullfrog Type Deposits with Belt-Wide Geophysical Survey

VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, OTCQX: CORVF) announces that it has initiated geophysical surveys throughout the Mother Lode trend to integrate district scale data into its belt-wide exploration models (Figure 1).  The greatly expanded survey as well as other ongoing regional studies and data compilations are designed to effectively and efficiently unlock the significant potential for new discoveries across the belt and throughout the greater Bullfrog Gold District.  In addition, Corvus has expanded its land position east of AngloGold Ashanti’s new Silicon discovery and north of a new large claim block recently staked by Kinross Gold (Figure 1).  Activity in the belt and the Bullfrog District in general is rapidly expanding with new claim...

Continue reading

Tree of Knowledge International Corp. Announces Launch of Post Covid-19 Community Care Program

Toronto, Ontario, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tree of Knowledge International Corp. (CSE: TOKI) (the “Company”) is pleased to announce that it will provide the first Multidisciplinary Post COVID-19 community clinics program through their owned and allied clinics. This planned post COVID-19 multidisciplinary clinical program will primarily start at 14 clinics in Ontario and Nova Scotia followed by expansion to other allied community clinics nationwide.The novel SARS COV-2 virus has affected close to 5 million people worldwide leading to a spectrum of acute COVID-19 presentations from asymptomatic carriers to severe multi-system organ failures and death. As the acute phase of this disease passes, many of recovered patients are showing chronic symptoms like body pain, fatigue or mental wellness...

Continue reading

Velocity Announces Positive Drill Results from the Sedefche Gold Project, Bulgaria

Highlights include:Drill hole SDD-074; 27.2m @ 3.17 g/t gold and 110 g/t silver,including 4.7m @ 9.75 g/t gold and 416 g/t silverDrill hole SDD-073; 45.4m @ 1.31 g/t gold and 44 g/t silverDrill hole SDD-049; 8.6m @ 3.77 g/t gold and 1004 g/t silver,VANCOUVER, British Columbia, May 19, 2020 (GLOBE NEWSWIRE) — Velocity Minerals Ltd. (TSX.V: VLC) (“Velocity” or the “Company”) announces that it has received results from 26 additional drill holes for the near-surface Sedefche gold project (“Sedefche”), Bulgaria.  Highlights include:Significant mineralization from near surface to depths of approximately 50m from surface:  SDD-074 returned 27.2m @ 3.24 g/t gold (3.17 g/t gold using a 20 g/t top cut) and 110.41 g/t silver.  Top cutting is done when samples return analysis in excess of 20 g/t gold; in this hole 1 sample was top cut from...

Continue reading

Bellerophon Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Registered Direct Offering

WARREN, N.J., May 19, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”) today announced the pricing of offerings for an aggregate of 3,076,923 shares of its common stock at a public offering price of $13.00 per share (the “Offerings”). The Offerings consisted of an underwritten public offering (the “Underwritten Offering”) of 1,923,077 shares and a registered direct offering (the “Direct Offering”) of 1,153,846 shares to an institutional investor affiliated with a member of the Company’s board of directors. Bellerophon has granted the underwriters of the Underwritten Offering a 30-day option to purchase up to an additional 288,461 shares of common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds to Bellerophon before deducting...

Continue reading

Agios Announces Publication of TIBSOVO® Phase 3 Data in The Lancet Oncology Demonstrating Significant Improvement in Progression-Free Survival Compared to Placebo in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients

– TIBSOVO® Is the First and Only IDH1 Inhibitor to Be Evaluated in a Phase 3 Clinical Trial for IDH1-Mutant Cholangiocarcinoma –CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that The Lancet Oncology has published data from its global Phase 3 ClarIDHy study of TIBSOVO® (ivosidenib) in previously treated cholangiocarcinoma patients with an isocitrate dehydrogenase 1 (IDH1) mutation. The study met its primary endpoint, demonstrating a statistically significant improvement in progression-free survival (PFS) in patients randomized to TIBSOVO® compared with placebo patients. The safety profile observed in the study was consistent with previously published data. Data from this study were...

Continue reading

FDA Approves Two Emergency INDs to Administer Organicell Flow for COVID-19

MIAMI, May 19, 2020 (GLOBE NEWSWIRE) — Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that on May 11, 2020, the U.S. Food and Drug Administration (FDA) authorized two Emergency Compassionate Use Investigational New Drug applications (eINDs), each for a single patient severely ill from COVID-19. These critical patients have received immediate administration of Organicell Flow.Organicell is collaborating with physicians at Landmark Hospital, a network of six hospitals located throughout the Southeast United States, to treat these patients for advanced complications associated with COVID-19. These patients were first treated with Organicell Flow on May 14, 2020 at Landmark Hospital in Athens, GA.   “These two patients...

Continue reading

RADA Electronic Industries Announces First Quarter 2020 Results

NETANYA, Israel, May 19, 2020 (GLOBE NEWSWIRE) — RADA Electronic Industries Ltd. (NASDAQ: RADA) announced today its financial results for the quarter ended March 31, 2020.Highlights of the first quarter of 2020Past and ongoing investments promoting strong growth, with quarterly revenues up 73% year-over-year to a record $15.1 million;Gross margin stability at 36%;Net income of $170,000 and positive Adjusted EBITDA of $863,000;US manufacturing facility ramping production;Quarter-end net cash position of $32.1 million.Reiterates 2020 revenues guidance in excess of $65 million, with continued sequential revenue growth throughout the year.Management CommentsDov Sella, RADA’s Chief Executive Officer commented, “Given the very significant opportunities we identified in the emerging business of mini-tactical radars a few years ago,...

Continue reading

innoAviation Helps Air Carriers Track Critical COVID-19–Related PPE Shipments with Descartes’ ULD Tracking Solution

WATERLOO, Ontario, May 19, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that innoAviation Limited, a leading unit load device (ULD) leasing and services provider, is using the Descartes CORE™ ULD Tracking solution as part of its service to help air carriers track critical COVID-19–related personal protective equipment (PPE) shipments.A significant percentage of air cargo coming from Asia today is PPE to fight COVID-19. Combined with an imbalance of ULDs, air carriers are challenged to move critical freight. innoAviation is leasing air carriers ULDs with Descartes Bluetooth Low Energy (BLE) tags and using Descartes CORE ULD Tracking to track shipments and better manage the ULDs. The cloud-based tracking solution supports...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.